stars 1 stars 2 stars 3

LexaGene Life Sciences is an early-stage company developing a novel automated PCR-based bioburden testing system. The technology will be a significant improvement in the key needs of speed, ease-of-use, and sensitivity for >95% of microbial contaminants. Our initial target market is the biopharmaceutical manufacturing industry.

LexaGene Questions

The LexaGene annual revenue was $4 million in 2026.

Steve Armstrong is the COO of LexaGene.

1 people are employed at LexaGene.

LexaGene is based in Beverly, Massachusetts.

The NAICS codes for LexaGene are [541715, 54, 54171, 541, 541714, 5417].

The SIC codes for LexaGene are [873, 87].

Top LexaGene Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users